Mr. Song Ruilin, Executive President of China Pharmaceutical Innovation and Research Development Association (PhIRDA), Advisor on Participation in and Deliberation of State Affairs for the Chinese People's Political Consultative Conference (CPPCC), Advisor on Participation in and Deliberation of State Affairs for the Central Committee of Chinese Peasants and Workers Democratic Party, Chairman of iMeta Health Information Consulting Co., Ltd.. He is also L.L.B. of China University of Political Science and Law, EMBA of China Europe International Business School, Doctor of Social and Administrative Pharmacy of China Pharmaceutical University and Visiting Scholar of the University of Sydney. Mr. Song had served in the Legislative Affairs Office at State Council of China for a long time, engaging in health and drug policy, legal studies and in charge of law making and reviewing in the areas of pharmaceutical and healthcare industry. In recent years, he mainly engages in the research on China's pharmaceutical innovation policy.

Currently, Mr. Song also undertakes several social positions, such as Executive Deputy Director of the Research Center of National Drug Policy & Ecosystem of China Pharmaceutical University, Visiting Research Fellow of Shanghai Jiao Tong University, Member of TCM Strategic Expert Consultation Committee of NMPA, Biotech Advisory Panel Member of the SEHK, Vice President of China Alliance for Rare Disease (CARD), Honorary Director of Chinese Pharmaceutical Association (CPA), Director of Chinese Pharmacists Association and Director of Bethune Charitable Foundation.